Standardization of safer doudenal ESD: analysis observation study of typical procedure of duodenal ESD
Not Applicable
- Conditions
- Duodenal adenoma or cancer
- Registration Number
- JPRN-UMIN000026184
- Lead Sponsor
- Ehime Rosai Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 75
Inclusion Criteria
Not provided
Exclusion Criteria
Exclusion criteria 1.Diagnosed with Diabetes Mellitus 2.Taking Steroid or immune suupress drugs 3.Chr.pancreatitis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie duodenal adenoma or cancer progression targeted by endoscopic submucosal dissection (ESD)?
How does duodenal ESD compare to traditional endoscopic mucosal resection (EMR) in treating early gastrointestinal cancers?
What biomarkers are used to select patients for endoscopic submucosal dissection (ESD) in duodenal neoplasms?
What are the most common adverse events associated with endoscopic submucosal dissection (ESD) in the duodenum and how are they managed?
What are the current drug classes or combination therapies being explored alongside endoscopic submucosal dissection (ESD) for duodenal cancer treatment?